In addition, we recorded dosages of the GLP-1-RA and of IIH medication, adherence to the GLP-1-RA treatment and adverse events (AEs) at M3 and M6
In the new study, Rodriguez and colleagues analyzed electronic health records from more than 41,000 adults who were overweight or had obesity and had been prescribed one of the two drugs for the first time
Eloralintide is not FDA-approved and is not available for prescription
This tapering is crucial to reduce the risk of adrenal insufficiency, a condition where the body cannot produce adequate amounts of natural steroids because the adrenal glands have been suppressed by the prednisone
Potential for Type 2 Diabetes Remission Disease Modulation : The significant weight loss and improved insulin sensitivity associated with semaglutide use can lead to partial or complete remission of type 2 diabetes, particularly when combined with lifestyle interventions as part of a comprehensive medical weight loss plan
AOD 9604 wins on simplicity: no titration required, stable dose from day one